LDS/Medical Tests/Coccidioides By Molecular Method, Body Fluid

Coccidioides By Molecular Method, Body Fluid

Coccidioidomycosis, also known as Valley Fever, is a fungal infection that is found in the southwestern United States, including Southern California, Arizona, Central and South America. The infection is caused by the thermally dimorphic fungus Coccidioides immitis or Coccidioides posadasii, and it occurs by breathing in spores from the soil. There are three categories of Coccidioidomycosis. The most common clinical presentation of coccidioidomycosis is pneumonia or primary pulmonary Coccidioidomycosis that becomes evident 1 – 3 weeks after infection. The cause of the pneumonia is difficult to distinguish from other causes and is usually only diagnosed after the other causes are ruled out. Coccidioidal pneumonia, although self-limiting, can have severe symptoms such as chest pain, fever, and rashes. If left untreated in immunocompromised patients such as HIV or organ transplant patients, the Coccidioides may become disseminated Cocciodiodomycosis and spread throughout the body, causing bone pain, joint pain, heart inflammation, or meningitis. The third type of Coccidioidomycosis is primary cutaneous Coccidioidomycosis, which is caused by Coccidioides immitis/posadasii coming into contact with a cut or sore on the skin, resulting in skin lesions. Although only 1% of the cases of Coccidioidomycosis present with severe symptoms, these cases usually have a high rate of morbidity. The new generation of antibody testing assays has very good sensitivity (>95%) and specificity (>98%). False positive results are seen in patients with blastomycosis and other noncoccidioidal disease. A combination of fungal culture and Coccidioides antibody testing will confirm the diagnosis of Coccidioidomycosis.

  • Diagnosis and treatment monitoring of coccidioidomycosis
  • Differential diagnosis of coccidioidomycosis in immunocompromised and HIV patients Note: Testing should be performed when pulmonary or neurologic symptoms are present and the patient lives in or has recently traveled to an endemic area.
Increased titers or the presence of IgM antibody usually indicates current infection. Rising titers in serial specimens are diagnostic of current infection. *Caution: IgG or IgM antibodies may be present after the infection is resolved. Cultures may be used to diagnose coccidioidomycosis in patients with disseminated disease.*

Negative
 

 

Real-time polymerase chain reaction (PCR), or other molecular methods. 

Body fluid collected in a sterile container or syringe. 

Stability

  • Ambient: 1-3 days
  • Refrigerated: 5-7 days
  • Frozen: 30 days
Fungal Culture (Coccidioides Culture), Blood, Biopsy or Body Fluid, Sputum, Coccidioides immitis by PCR, Skin Test, Complement Fixation Test.

1-3 days. 

Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • West J Med. 1993 Aug;159(2):153-71. [PMID: 8212681]
  • Clin Infect Dis. 2005;41:1217. [PMID: 16206093]
  • Clin Infect Dis. 2006;42:103. [PMID: 16323099]
  • Burtis C, Ashwood E, and Bruns D. Fundamentals of Clinical Chemistry. St. Louis: Saunders (2008).